Anti-Ge3 causes late-onset hemolytic disease of the newborn: The fourth case in three Hispanic families

Transfusion

Volumn 53, Issue 10, 2013, Pages 2152-2157

  Pate, Lisa Lee ^a   Myers, Jessica C ^a   Palma, Jonathan P ^a   Viele, Maurene ^a   Galel, Susan A ^a   Ferrer, Zenaida ^a   Gonzalez, Christopher L ^a   Benitz, William E ^a   Garratty, George ^a   Fontaine, Magali J ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; ERYTHROCYTE ANTIGEN; GERBICH ANTIGEN; IMMUNOGLOBULIN; RECOMBINANT ERYTHROPOIETIN; UNCLASSIFIED DRUG;

APGAR SCORE; ARTICLE; BILIRUBIN BLOOD LEVEL; CASE REPORT; CESAREAN SECTION; COOMBS TEST; EMERGENCY SURGERY; ERYTHROCYTE TRANSFUSION; ETHNICITY; EXCHANGE BLOOD TRANSFUSION; FEMALE; FETUS MOVEMENT; GESTATIONAL AGE; HEMATOCRIT; HEMOLYSIS; HISPANIC; HOSPITAL DISCHARGE; HUMAN; HYPERBILIRUBINEMIA; INTRAUTERINE BLOOD TRANSFUSION; LABORATORY DIAGNOSIS; NEWBORN; NEWBORN HEMOLYTIC DISEASE; NEWBORN INTENSIVE CARE; NEWBORN JAUNDICE; PHOTOTHERAPY; PRENATAL CARE; TACHYCARDIA;

ADULT; BLOOD GROUP ANTIGENS; ERYTHROBLASTOSIS, FETAL; ERYTHROPOIETIN; FEMALE; HUMANS; INFANT, NEWBORN;

EID: 84885732103     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12027     Document Type: Article

References (27)

1. Koelewijn JM, Vrijkotte TG, van der, Schoot CE, Bonsel GJ, de, Haas M,. Effect of screening for red cell antibodies other than anti-D to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands. Transfusion 2008; 48: 941-952. (Pubitemid 351614905)
2. Gottvall T, Filbey D,. Alloimmunization in pregnancy during the years 1992-2005 in the central west region of Sweden. Acta Obstet Gynecol Scand 2008; 87: 843-848.
3. Walker PS, Reid ME,. The Gerbich blood group system: a review. Immunohematology 2010; 26: 60-65.
4. Baughn MR, Whitacre P, Lo GS, Pandey S, Lane TA,. A mild acute hemolytic transfusion reaction in a patient with alloanti-Ge: a case report and review of the literature. Transfusion 2011; 51: 1966-1971.
5. Arndt P, Garratty G, Do J, Hunt P,. First example of anti-Ge associated with severe hemolytic disease of the newborn [abstract]. Transfusion 2002; 42: 19S.
6. Arndt PA, Garratty G, Daniels G, Green CA, Wilkes AM, Hunt P, Do J, Glenn S, Peterson D,. Late onset neonatal anemia due to maternal anti-Ge: possible association with destruction of erythroid progenitors. Transfus Med 2005; 15: 125-132. (Pubitemid 40663543)
7. Blackall DP, Pesek GD, Montgomery MM, Oza KK, Arndt PA, Garratty G, Shahcheraghi A, Denomme GA,. Hemolytic disease of the fetus and newborn due to anti-Ge3: combined antibody-dependent hemolysis and erythroid precursor cell growth inhibition. Am J Perinatol 2008; 25: 541-545.
8. Rosenfield RE, Haber GV, Kissmeyer-Nielsen F, Jack JA, Sanger R, Race RR,. Ge, a very common red-cell antigen. Br J Haematol 1960; 6: 344-349.
9. Vaughan JI, Warwick R, Letsky E, Nicolini U, Rodeck CH, Fisk NM,. Erythropoietic suppression in fetal anemia because of Kell alloimmunization. Am J Obstet Gynecol 1994; 171: 247-252. (Pubitemid 24254449)
10. Weiner CP, Widness JA,. Decreased fetal erythropoiesis and hemolysis in Kell hemolytic anemia. Am J Obstet Gynecol 1996; 174: 547-551. (Pubitemid 26070140)
11. Vaughan JI, Manning M, Warwick RM, Letsky EA, Murray NA, Roberts IA,. Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia. N Engl J Med 1998; 338: 798-803. (Pubitemid 28135986)
12. Daniels G, Hadley A, Green CA,. Causes of fetal anemia in hemolytic disease due to anti-K. Transfusion 2003; 43: 115-116. (Pubitemid 36322905)
13. Southcott MJG, Tanner MJA, Anstee DJ,. The expression of human blood group antigens during erythropoiesis in a cell culture system. Blood 1999; 93: 4425-4435. (Pubitemid 29279286)
14. Bony V, Gane P, Bailly P, Cartron JP,. Time-course expression of polypeptides carrying blood group antigens during human erythroid differentiation. Br J Haematol 1999; 107: 263-274. (Pubitemid 29530210)
15. Daniels G, Green C,. Expression of red cell surface antigens during erythropoiesis. Vox Sang 2000; 78 (S2): 149-153.
16. Denomme GA, Shahcheraghi A, Blackall DP, Oza KK, Garratty G,. Inhibition of erythroid progenitor cell growth by anti-Ge3. Br J Haematol 2006; 113: 443-450.
17. Hurdle ADF, Davis JA,. The "late" anaemia of haemolytic disease of the newborn. Br J Haematol 1965; 11: 247-257.
18. Gasser C,. Pure red cell anemia due to autoantibodies: immune-type of aplastic anemia, erythroblastopenia. Sang 1955; 26: 6-13.
19. Giblett ER, Varela JE, Finch CA,. Damage to the bone marrow due to Rh antibody. Pediatrics 1956; 17: 37-44.
20. Lindquist B, Ryttinger L,. Decreased bone marrow function in hemolytic disease of the newborn: report of a case with severe anemia and prolonged persistence of antibodies. Acta Paediatr 1959; 48: 501-506.
21. Hurdle ADF, Walker AG,. Bone marrow hypoplasia in the course of haemolytic disease of the newborn. BMJ 1963; 1: 518-520.
22. Luban NLC,. Hemolytic disease of the newborn: progenitor cells and late effects. N Engl J Med 1998; 338: 830-831. (Pubitemid 28135992)
23. Van Wamelen DJ, Klumper FJ, de, Haas M, Meerman RH, van, Kamp IL, Oepkes D,. Obstetric history and antibody titer in estimating severity of Kell alloimmunization in pregnancy. Obstet Gynecol 2007; 109: 1093-1098. (Pubitemid 46685951)
24. Gottstein R, Cooke RWI,. Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn. Arch Dis Child Fetal Neonatal Ed 2003; 88: F6-F10. (Pubitemid 36084200)
25. Micieli JA, Wang D, Denomme GA,. Anti-glycophorin C induces mitochondrial membrane depolarization and a loss of extracellular regulated kinase 1/2 protein kinase activity that is prevented by pretreatment with cytochalasin D: implications for hemolytic disease of the fetus and newborn caused by anti-Ge3. Transfusion 2010; 50: 1761-1765.
26. Reid ME, Lomas-Francis C,. Antigen based facts in the blood group antigen facts book. 2nd ed. New York: Academic Press; 2004.
27. Arndt PA, Leger RM, Garratty G,. Clinical significance of anti-Ge2 vs. anti-Ge3 [abstract]. Transfusion 2012; 52: 143A.